Literature DB >> 17226957

Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.

Derek S Youngblood1, Susie A Hatlevig, Jed N Hassinger, Patrick L Iversen, Hong M Moulton.   

Abstract

Cell penetrating peptides (CPPs) have been shown to enhance the cellular uptake of antisense oligonucleotides (AOs). However, the effectiveness of the CPPs for cytoplasmic or nuclear delivery of therapeutic AOs must take into account the possible entrapment of the CPP-AO conjugates in endosomes/lysosomes and the overall stability of the CPP-AO conjugates to enzymes. This includes the stabilities of the CPPs and AOs themselves as well as the linkage between them. In this study, we investigated the effects of several structural features of arginine-rich CPPs on the metabolic stability of CPP conjugated to phosphorodiamidate morpholino oligomers (PMOs) in human serum and in cells. Those structural features include amino acid configurations (d or l), incorporation of non-alpha-amino acids, peptide sequences, and types of linkages between CPPs and PMOs. Using matrix-assisted laser desorption ionization time-of-flight mass spectrometry, we found that the stability of the CPP portion was varied although the PMO portion of the conjugate was completely stable both in cells and in human serum. d-Configuration CPPs were completely stable, while l-CPPs were degraded in both serum and HeLa cells. Insertions of 6-aminohexanoic acid residues (X) into an R8 peptide increased the corresponding CPP's serum stability with the degree of stability being dependent upon the positions of X. However, X-containing CPPs were degraded rapidly intracellularly. Insertions of beta-alanines (B) into the R8 peptide increased its serum stability and intracellular stability. An amide or a maleimide linkage was stable in both serum and cells; however, an unhindered disulfide linkage was not stable in either. By using fluorescent microscopy, flow cytometry, and an antisense splice correction assay, the cellular uptakes of an X-containing conjugate and its fragments were compared to their antisense activities. We found that a large fraction of the conjugate was trapped within vesicles and the degraded fragments cannot escape from the vesicles. This study indicates that the incorporation of non-alpha-amino acids into l-CPPs can increase the metabolic stability of CPP-PMOs without using costly d-CPPs. However, the position and type of non-alpha-amino acids affect the degree of stability extracellularly and intracellularly. In addition, this study reveals that the degradation of an X-containing CPP-PMO conjugate is a more rapid process than degradation of a B-containing conjugate. Last, the endosomal/lysosomal trapping limits the effectiveness of a CPP-PMO conjugate, and the stability of the CPP is one of the factors affecting the ability of the conjugate to escape the endosomes/lysosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226957     DOI: 10.1021/bc060138s

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  57 in total

1.  Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  Yan-Jin Zhang; Rheba S Bonaparte; Deendayal Patel; David A Stein; Patrick L Iversen
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

Review 2.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

3.  Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures.

Authors:  Christina Foerg; Kathrin M Weller; Helene Rechsteiner; Hanne M Nielsen; Jimena Fernández-Carneado; René Brunisholz; Ernest Giralt; Hans P Merkle
Journal:  AAPS J       Date:  2008-06-28       Impact factor: 4.009

4.  Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum.

Authors:  Liutao Du; Refik Kayali; Carmen Bertoni; Francesca Fike; Hailiang Hu; Patrick L Iversen; Richard A Gatti
Journal:  Hum Mol Genet       Date:  2011-05-16       Impact factor: 6.150

5.  An l- to d-Amino Acid Conversion in an Endosomolytic Analog of the Cell-penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape.

Authors:  Kristina Najjar; Alfredo Erazo-Oliveras; Dakota J Brock; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  J Biol Chem       Date:  2016-12-06       Impact factor: 5.157

6.  Synthesis, Characterization, and Function of an RNA-Based Transfection Reagent.

Authors:  Harsh V Jain; Jessica F Boehler; Kanneboyina Nagaraju; Serge L Beaucage
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2018-03

7.  Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner.

Authors:  Yu-Min Wang; Michael Patrick Trinh; Yongzan Zheng; Kaizhu Guo; Luis A Jimenez; Wenwan Zhong
Journal:  Trends Analyt Chem       Date:  2019-07-05       Impact factor: 12.296

8.  Morpholino-mediated knockdown in primary chondrocytes implicates Hoxc8 in regulation of cell cycle progression.

Authors:  Suzan Kamel; Claudia Kruger; J Michael Salbaum; Claudia Kappen
Journal:  Bone       Date:  2008-11-21       Impact factor: 4.398

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.